Dextran Sulfate-Cellulose Adsorption in the Management of a Myeloma Patient with Renal Amyloidosis

Yorioka N. , Taniguchi Y. , Nishida Y. , Okushin S. , Amimoto D. , Yamakido M. Low-density lipoprotein apheresis for focal glomerular sclerosis. Therapeutic Apheresis 1997; 1: 370–1.

Busnach G. , Franceschini G. , Chiesa G. Impaired efficacy of selective LDL-apheresis in primary biliary cirrhosis. Int J Artif Organs 1991; 14: 246–50.

Arai H. , Nagumo K. , Nakajima M. , Kojima S. , Hirayama K. , Yamazaki M. Effect of low-density lipoprotein apheresis on a patient with cerebrotendinous xanthomatosis. Jpn J Apheresis 1995; 14: 59–60.

Yanagisawa T. , Otsubo O. , Nozaki H. Massive proteinuria after renal transplantation treated with LDL-apheresis. Transplant Proc 1996; 28: 1482–3.

Kanemitsu S. , Takekoshi N. , Matsui S. Short-term and long-term effects of low-density lipoprotein (LDL) apheresis on restenosis after percutaneous transluminal coronary angioplasty (PTCA): is lowering Lp(a) by LDL apheresis effective on restenosis after PTCA? Therapeutic Apheresis 1998; 2: 65–70.

Yoshidome H. , Kuriyama M. , Fujiyama M. , Osame M. Serum amyloid A and P protein levels are lowered by dextran sulfate cellulose low-density lipoprotein apheresis. Artif Organs 1998; 22: 144–8.

Taniguchi Y. , Yorioka N. , Yamashita K. Immunohistochemical localization of apolipoprotein E in renal amyloidosis. Hiroshima J Med Sci 1996; 45: 11–4.

Ruan X.Z. , Varghese Z. , Fernando R. , Moorhead J.F. Cytokine regulation of low-density lipoprotein receptor gene transcription in human mesangial cells. Nephrol Dial Transplant 1998; 13: 1391–7.